Clinical trials
Completed Observational Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
182 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 7 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 9 |
| 2009 | 14 |
| 2010 | 14 |
| 2011 | 7 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 12 |
| 2015 | 13 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 9 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 182 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Cancer Hospital & Institute | 5 |
| M.D. Anderson Cancer Center | 4 |
| National Cancer Institute (NCI) | 4 |
| Pfizer | 4 |
| iOMEDICO AG | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Bristol-Myers Squibb | 3 |
| Centre Leon Berard | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 3 |
| Merck KGaA, Darmstadt, Germany | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 182 |
| Breast Neoplasms | 32 |
| Neoplasms | 23 |
| Colorectal Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Carcinoma, Hepatocellular | 11 |
| Lung Neoplasms | 10 |
| Prostatic Neoplasms | 10 |
| Recurrence | 9 |
| Brain Neoplasms | 8 |
Trials
Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.
82 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.